




Searching News Database: adhesions
HSMN NewsFeed - 23 Aug 2017
Channel Medsystems(R) Secures $14.1mm Financing for Office-Based Treatment of Heavy Menstrual Bleeding
Channel Medsystems(R) Secures $14.1mm Financing for Office-Based Treatment of Heavy Menstrual Bleeding
HSMN NewsFeed - 26 Jun 2017
Channel Medsystems(R) Earns CE Mark Approval for the Cerene(R) Cryotherapy Device
Channel Medsystems(R) Earns CE Mark Approval for the Cerene(R) Cryotherapy Device
HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
HSMN NewsFeed - 13 Aug 2015
Innocoll AG Appoints Rich Fante as Chief Commercial Officer and Head of Business Development
Innocoll AG Appoints Rich Fante as Chief Commercial Officer and Head of Business Development
HSMN NewsFeed - 23 Apr 2014
The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio
The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio
HSMN NewsFeed - 15 Nov 2011
Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
HSMN NewsFeed - 11 Oct 2011
Innocoll Announces European Approval for CollaGUARD(R), Surgical Adhesion Barrier
Innocoll Announces European Approval for CollaGUARD(R), Surgical Adhesion Barrier
HSMN NewsFeed - 9 Mar 2009
FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
HSMN NewsFeed - 21 Jan 2009
Novel Product for Post Surgical Scar Formation Entering Clinical Development
Novel Product for Post Surgical Scar Formation Entering Clinical Development
HSMN NewsFeed - 2 Oct 2008
Covidien Introduces the SprayShield(TM) Adhesion Barrier System to the European Marketplace
Covidien Introduces the SprayShield(TM) Adhesion Barrier System to the European Marketplace
HSMN NewsFeed - 18 Jul 2008
SyntheMed Appoints Corinne Mundin as Director, International Market Development
SyntheMed Appoints Corinne Mundin as Director, International Market Development
HSMN NewsFeed - 17 Jun 2008
NeoMend Receives FDA Panel's Recommendation for Approval of ProGEL(TM) Surgical Sealant
NeoMend Receives FDA Panel's Recommendation for Approval of ProGEL(TM) Surgical Sealant
HSMN NewsFeed - 21 Jan 2008
Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO
Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO
HSMN NewsFeed - 20 Sep 2007
FDA Panel Recommends Approval of SyntheMed's REPEL-CV(R) Adhesion Barrier for Pediatric Patients
FDA Panel Recommends Approval of SyntheMed's REPEL-CV(R) Adhesion Barrier for Pediatric Patients
HSMN NewsFeed - 2 Jul 2007
Tenaxis Medical Inc. Announces First Human Use of ArterX(TM) Vascular Sealant
Tenaxis Medical Inc. Announces First Human Use of ArterX(TM) Vascular Sealant
HSMN NewsFeed - 28 Mar 2007
FDA Accepts Synthemed's Pre-Market Approval (PMA) Application for REPEL-CV(R)
FDA Accepts Synthemed's Pre-Market Approval (PMA) Application for REPEL-CV(R)
HSMN NewsFeed - 11 Jan 2007
Synovis Life Technologies Granted Important FDA Indication and U.S. Patent for Veritas(R) Collagen Matrix
Synovis Life Technologies Granted Important FDA Indication and U.S. Patent for Veritas(R) Collagen Matrix
HSMN NewsFeed - 16 Nov 2006
Comprehensive Review Published on FzioMed Technology for Postsurgical Adhesion Prevention
Comprehensive Review Published on FzioMed Technology for Postsurgical Adhesion Prevention
HSMN NewsFeed - 13 Oct 2006
Independent Studies on FzioMed's Anti-Adhesion Gel Presented at Spine Meetings
Independent Studies on FzioMed's Anti-Adhesion Gel Presented at Spine Meetings
HSMN NewsFeed - 6 Sep 2006
SyntheMed Announces Positive Pivotal Clinical Trial Results for REPEL-CV(R)
SyntheMed Announces Positive Pivotal Clinical Trial Results for REPEL-CV(R)
Additional items found! 52

Members Archive contains
52 additional stories matching:
adhesions
(Password required)
adhesions
(Password required)